Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling
Options
Publisher DOI
PubMed ID
22403047
Description
Clazosentan, an endothelin receptor antagonist, has been shown to reduce vasospasm after aneurysmal subarachnoid hemorrhage (aSAH). CONSCIOUS-3 assessed whether clazosentan reduced vasospasm-related morbidity and all-cause mortality postaSAH secured by endovascular coiling.
Date of Publication
2012
Publication Type
Article
Language(s)
en
Contributor(s)
Macdonald, R Loch | |
Higashida, Randall T | |
Keller, Emanuela | |
Mayer, Stephan A | |
Molyneux, Andy | |
Vajkoczy, Peter | |
Wanke, Isabel | |
Bach, Doris | |
Frey, Aline | |
Nowbakht, Pegah | |
Roux, Sébastien | |
Kassell, Neal |
Additional Credits
Series
Stroke
Publisher
Lippincott Williams & Wilkins
ISSN
0039-2499
Access(Rights)
metadata.only